These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9343504)

  • 1. HIV-1 in semen: an isolated virus reservoir.
    Byrn RA; Zhang D; Eyre R; McGowan K; Kiessling AA
    Lancet; 1997 Oct; 350(9085):1141. PubMed ID: 9343504
    [No Abstract]   [Full Text] [Related]  

  • 2. Shedding of HIV-1 in semen during primary infection.
    Dyer JR; Gilliam BL; Eron JJ; Cohen MS; Fiscus SA; Vernazza PL
    AIDS; 1997 Mar; 11(4):543-5. PubMed ID: 9084808
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir.
    Byrn RA; Kiessling AA
    J Reprod Immunol; 1998 Dec; 41(1-2):161-76. PubMed ID: 10213308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.
    Sheth PM; Kovacs C; Kemal KS; Jones RB; Raboud JM; Pilon R; la Porte C; Ostrowski M; Loutfy M; Burger H; Weiser B; Kaul R;
    AIDS; 2009 Sep; 23(15):2050-4. PubMed ID: 19710596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 viral load in blood and semen plasma of Brazilian patients under antiretroviral therapy.
    Medeiros RP; Munerato P; Diaz RS
    J Clin Virol; 2004 Aug; 30(4):346-7. PubMed ID: 15163426
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 7. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir.
    Kiessling AA; Fitzgerald LM; Zhang D; Chhay H; Brettler D; Eyre RC; Steinberg J; McGowan K; Byrn RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S33-41. PubMed ID: 9581882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for the transmission of HIV-1 despite highly active antiretroviral therapy.
    Haase AT; Schacker TW
    N Engl J Med; 1998 Dec; 339(25):1846-8. PubMed ID: 9854123
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures.
    La Sala GB; Pilotti E; Nicoli A; Pinelli S; Villani MT; Ronzi P; Zendri E; Re MC; Magnani G; Casoli C
    AIDS; 2007 Jan; 21(3):377-9. PubMed ID: 17255749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HIV-1 variation in blood and semen during treatment and treatment interruption.
    Choudhury B; Pillay D; Taylor S; Cane PA
    J Med Virol; 2002 Dec; 68(4):467-72. PubMed ID: 12376952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of protease and reverse transcriptase drug resistance mutations in naïve HIV-infected patients.
    Valle-Bahena OM; Ramos-Jiménez J; Ortiz-López R; Revol A; Lugo-Trampe A; Barrera-Saldaña HA; Rojas-Martínez A
    Arch Med Res; 2006 Nov; 37(8):1022-7. PubMed ID: 17045121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance within the protease inhibitor class.
    Race E
    Antivir Ther; 2001; 6 Suppl 2():29-36. PubMed ID: 11678476
    [No Abstract]   [Full Text] [Related]  

  • 13. Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.
    Winters MA; Merigan TC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2575-82. PubMed ID: 15980322
    [No Abstract]   [Full Text] [Related]  

  • 14. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
    Zhang H; Dornadula G; Beumont M; Livornese L; Van Uitert B; Henning K; Pomerantz RJ
    N Engl J Med; 1998 Dec; 339(25):1803-9. PubMed ID: 9854115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections.
    Taylor S; Sadiq ST; Weller I; Kaye S; Workman J; Cane PA; Bennett J; Copas AJ; Drake SM; Pillay D
    Antivir Ther; 2003 Oct; 8(5):479-83. PubMed ID: 14640396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [AIDS: new developments. VI. HIV reservoirs during intensive antiretroviral treatment].
    Notermans DW; Danner SA; de Wolf F; Lange JM
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1909-12. PubMed ID: 9856176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.
    Pereira AS; Kashuba AD; Fiscus SA; Hall JE; Tidwell RR; Troiani L; Dunn JA; Eron JJ; Cohen MS
    J Infect Dis; 1999 Dec; 180(6):2039-43. PubMed ID: 10558966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with changes in HIV shedding in semen.
    Fiscus SA; Vernazza PL; Gilliam B; Dyer J; Eron JJ; Cohen MS
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S27-31. PubMed ID: 9581881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy.
    Mayer KH; Boswell S; Goldstein R; Lo W; Xu C; Tucker L; DePasquale MP; D'Aquila R; Anderson DJ
    Clin Infect Dis; 1999 Jun; 28(6):1252-9. PubMed ID: 10451162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.